STRATEGY STUDIO / NONPROFIT PEOPLE SEARCH

NEW YORK GENOME CENTER INC: Form 990, tax year 2017

View the entire original 990 at ProPublica ↗

Organization
NEW YORK GENOME CENTER INC (EIN 80-0631734)
Tax period
2017-01-01 to 2017-12-31
Filed
2018-11-13
IRS object ID
201833179349301323
Schema version
2017v2.3
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2018-11-13T08:38:46-06:00ReturnTs
Tax Period End2017-12-31TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1KPMG LLPBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line1345 Park AvenueAddressLine1Txt
CityNew YorkCityNm
State AbbreviationNYStateAbbreviationCd
ZIP101540102ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2017-01-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN800631734EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1NEW YORK GENOME CENTER INCBusinessNameLine1Txt
FieldValueIRS element (for citing)
In Care Of% NANCY KONGInCareOfNm
Business Name ControlNEWYBusinessNameControlTxt
Phone6469777000PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1101 AVENUE OF THE AMERICAS Suite 7TAddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP10013ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonELIZABETH O'BRIENPersonNm
Person TitleVP & GENERAL COUNSELPersonTitleTxt
Phone6469777000PhoneNum
Signature2018-11-12SignatureDt
Discuss With Paid PreparerYes (true)DiscussWithPaidPreparerInd

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonNICOLE A FITZMAURICEPreparerPersonNm
PTINP01491005PTIN
Phone2127589700PhoneNum
Preparation2018-11-12PreparationDt

Filing Security Information FilingSecurityInformation

IP Address IPAddress

FieldValueIRS element (for citing)
I Pv4 Address167.68.102.5IPv4AddressTxt
FieldValueIRS element (for citing)
Federal Original Submission Id13407320183175000008FederalOriginalSubmissionId
Federal Original Submission Id2018-11-13FederalOriginalSubmissionIdDt
Filing License TypePFilingLicenseTypeCd
At Submission Creation Device Id9DD58F112FDB1D6FC5ED64343B33E2E6300E3CA8AtSubmissionCreationDeviceId
At Submission Filing Device IdB09A8F7452AAEB109EF01FBCB66ABFE0CB6B8889AtSubmissionFilingDeviceId
FieldValueIRS element (for citing)
Tax2017TaxYr
Build TS2019-02-21 02:37:17ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Principal OfficerCHERYL A MOOREPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line1101 AVENUE OF THE AMERICASAddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP10013ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$94,913,836GrossReceiptsAmt
Group Return For AffiliatesfalseGroupReturnForAffiliatesInd
Organization501c3Yes (X)Organization501c3Ind
Website Addresswww.nygenome.orgWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation2010FormationYr
Legal Domicile StateDELegalDomicileStateCd
Activity Or MissionNYGC IS AN INDEPENDENT, NONPROFIT ACADEMIC RESEARCH INSTITUTION DEDICATED TO ADVANCING PATIENT CARE THROUGH DISEASE-BASED GENOME RESEARCH.ActivityOrMissionDesc
Voting Members Governing Body25VotingMembersGoverningBodyCnt
Voting Members Independent23VotingMembersIndependentCnt
Total Employee232TotalEmployeeCnt
Total Volunteers24TotalVolunteersCnt
Total Gross UBI$855,443TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm-$192,555NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$94,901,046PYContributionsGrantsAmt
CY Contributions Grants$70,723,214CYContributionsGrantsAmt
PY Program Service Revenue$37,095,198PYProgramServiceRevenueAmt
CY Program Service Revenue$23,716,598CYProgramServiceRevenueAmt
PY Investment Income$23,269PYInvestmentIncomeAmt
CY Investment Income$88,421CYInvestmentIncomeAmt
PY Other Revenue$58,024PYOtherRevenueAmt
CY Other Revenue$95,299CYOtherRevenueAmt
PY Total Revenue$132,077,537PYTotalRevenueAmt
CY Total Revenue$94,623,532CYTotalRevenueAmt
PY Grants And Similar Paid$444,802PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$991,540CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$32,325,804PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$30,157,920CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$130,033PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$140,000CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$1,231,122CYTotalFundraisingExpenseAmt
PY Other Expenses$65,312,805PYOtherExpensesAmt
CY Other Expenses$60,996,415CYOtherExpensesAmt
PY Total Expenses$98,213,444PYTotalExpensesAmt
CY Total Expenses$92,285,875CYTotalExpensesAmt
PY Revenues Less Expenses$33,864,093PYRevenuesLessExpensesAmt
CY Revenues Less Expenses$2,337,657CYRevenuesLessExpensesAmt
Total Assets BOY$122,070,905TotalAssetsBOYAmt
Total Assets EOY$114,196,275TotalAssetsEOYAmt
Total Liabilities BOY$82,869,747TotalLiabilitiesBOYAmt
Total Liabilities EOY$72,657,460TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$39,201,158NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$41,538,815NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionOPERATE A STATE-OF-THE-ART, WORLD CLASS GENOME SEQUENCING, BIOINFORMATICS AND RESEARCH CENTER IN NEW YORK CITY. FOR MORE INFORMATION, SEE SCHEDULE O.MissionDesc
Significant New Program SrvcfalseSignificantNewProgramSrvcInd
Significant ChangefalseSignificantChangeInd
Expense$38,391,900ExpenseAmt
Revenue$14,844,068RevenueAmt
DescRESEARCH SEQUENCING IN 2017, NEW YORK GENOME CENTER (NYGC) SEQUENCED TENS OF THOUSANDS OF WHOLE GENOME SAMPLES, COMPLETED 780 PROJECTS, AND COLLABORATED WITH 190 INVESTIGATORS FROM 110 INSTITUTIONS WORLDWIDE. AS OF DECEMBER 2017, NYGCS HAD 5 ILLUMINA NOVASEQ INSTRUMENTS, 14 ILLUMINA HISEQ X INSTRUMENTS AND 12 ILLUMINA HISEQ 2500 INSTRUMENTS. FOR MORE INFORMATION, SEE SCHEDULE O.Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

FieldValueIRS element (for citing)
Expense$24,176,450ExpenseAmt
Grant$991,540GrantAmt
Revenue$2,350,599RevenueAmt
DescRESEARCH OUR RESEARCH SCIENTISTS AND FACULTY ARE EXPLORING GENOMIC CONTRIBUTORS TO HUMAN DISEASE, BOTH IN THEIR OWN PROJECTS AND THROUGH COLLABORATIONS. NYGC RESEARCHERS HAVE PROJECTS UNDERWAY IN CANCER, INCLUDING LUNG, LIVER, BREAST AND MELANOMA; NEURODEGENERATIVE DISEASES, FOCUSING ON ALS; AND AUTISM, AMONG MANY OTHERS. OUR BIOINFORMATICS SCIENTISTS PLAY A LEADERSHIP ROLE IN THE COMPLEX ANALYSIS OF DATASETS, INCLUDING INTEGRATING AND HARMONIZING CLINICAL AND GENOMIC DATA NECESSARY FOR ADVANCED RESEARCH. FOR MORE INFORMATION, SEE SCHEDULE O.Desc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

FieldValueIRS element (for citing)
Expense$5,278,717ExpenseAmt
Revenue$6,521,931RevenueAmt
DescCLINICAL SEQUENCING - NYGC IS AUTHORIZED BY THE NEW YORK STATE DEPARTMENT OF HEALTH TO OFFER THE FOLLOWING APPROVED CLINICAL TESTS THROUGH ITS CLEP/CLIA-CERTIFIED CLINICAL LABORATORY: CONSTITUTIONAL WHOLE GENOME SEQUENCING FOR UNDIAGNOSED DISEASE, CONSTITUTIONAL WHOLE GENOME SEQUENCING FOR PREDISPOSITIONAL GENETIC SCREENING, ONCOLOGY WHOLE EXOME AND TRANSCRIPTOME SEQUENCING, CONSTITUTIONAL WHOLE EXOME SEQUENCING, TARGETED SANGER SEQUENCING FOR VARIANT CONFIRMATION, AND SEQUENCING OF PREPARED LIBRARIES FOR MGTL.Desc
FieldValueIRS element (for citing)
Total Program Service Expenses$67,847,067TotalProgramServiceExpensesAmt
Described In Section501c3Yes (true)DescribedInSection501c3Ind
Schedule B RequiredYes (true)ScheduleBRequiredInd
Political Campaign ActyfalsePoliticalCampaignActyInd
Lobbying ActivitiesYes (true)LobbyingActivitiesInd
Subject To Proxy TaxfalseSubjectToProxyTaxInd
Donor Advised FundfalseDonorAdvisedFundInd
Conservation EasementsfalseConservationEasementsInd
Collections Of ArtfalseCollectionsOfArtInd
Credit CounselingfalseCreditCounselingInd
Temp Or Permanent EndowmentsfalseTempOrPermanentEndowmentsInd
Report Land Building EquipmentYes (true)ReportLandBuildingEquipmentInd
Report Investments Other SecfalseReportInvestmentsOtherSecInd
Report Program Related InvstfalseReportProgramRelatedInvstInd
Report Other AssetsYes (true)ReportOtherAssetsInd
Report Other LiabilitiesYes (true)ReportOtherLiabilitiesInd
Include FIN48 FootnoteYes (true)IncludeFIN48FootnoteInd
Independent Audit Fincl StmtYes (true)IndependentAuditFinclStmtInd
Consolidated Audit Fincl StmtfalseConsolidatedAuditFinclStmtInd
School OperatingfalseSchoolOperatingInd
Foreign OfficeYes (true)ForeignOfficeInd
Foreign ActivitiesYes (true)ForeignActivitiesInd
More Than5000 K To OrgfalseMoreThan5000KToOrgInd
More Than5000 K To IndividualsfalseMoreThan5000KToIndividualsInd
Professional FundraisingYes (true)ProfessionalFundraisingInd
Fundraising ActivitiesfalseFundraisingActivitiesInd
Gaming ActivitiesfalseGamingActivitiesInd
Operate HospitalfalseOperateHospitalInd
Grants To OrganizationsYes (true)GrantsToOrganizationsInd
Grants To IndividualsfalseGrantsToIndividualsInd
Schedule J RequiredYes (true)ScheduleJRequiredInd
Tax Exempt BondsfalseTaxExemptBondsInd
Engaged In Excess Benefit TransfalseEngagedInExcessBenefitTransInd
PY Excess Benefit TransfalsePYExcessBenefitTransInd
Loan OutstandingfalseLoanOutstandingInd
Grant To Related PersonfalseGrantToRelatedPersonInd
Business Rln With Org MemfalseBusinessRlnWithOrgMemInd
Business Rln With Fam MemfalseBusinessRlnWithFamMemInd
Business Rln With Officer EntfalseBusinessRlnWithOfficerEntInd
Deductible Non Cash ContrifalseDeductibleNonCashContriInd
Deductible Art ContributionfalseDeductibleArtContributionInd
Terminate OperationsfalseTerminateOperationsInd
Partial LiquidationfalsePartialLiquidationInd
Disregarded EntityfalseDisregardedEntityInd
Related EntityfalseRelatedEntityInd
Related Organization Ctrl EntfalseRelatedOrganizationCtrlEntInd
Trnsfr Exmpt Non Chrtbl Rltd OrgfalseTrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted PrtshpfalseActivitiesConductedPrtshpInd
Schedule O RequiredYes (true)ScheduleORequiredInd
IRP Document73IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Backup Wthld ComplianceYes (true)BackupWthldComplianceInd
Employee232EmployeeCnt
Employment Tax Returns FiledYes (true)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over LimitYes (true)UnrelatedBusIncmOverLimitInd
Form990 T FiledYes (true)Form990TFiledInd
Foreign Financial AccountfalseForeignFinancialAccountInd
Prohibited Tax Shelter TransfalseProhibitedTaxShelterTransInd
Taxable Party NotificationfalseTaxablePartyNotificationInd
Nondeductible ContributionsfalseNondeductibleContributionsInd
Quid Pro Quo ContributionsfalseQuidProQuoContributionsInd
Form8282 Property Disposed OffalseForm8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft CntrctfalseRcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft CntrctfalsePayPremiumsPrsnlBnftCntrctInd
Indoor Tanning ServicesfalseIndoorTanningServicesInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members25GoverningBodyVotingMembersCnt
Independent Voting Member23IndependentVotingMemberCnt
Family Or Business RlnfalseFamilyOrBusinessRlnInd
Delegation Of Mgmt DutiesfalseDelegationOfMgmtDutiesInd
Change To Org DocumentsfalseChangeToOrgDocumentsInd
Material Diversion Or MisusefalseMaterialDiversionOrMisuseInd
Members Or StockholdersYes (true)MembersOrStockholdersInd
Election Of Board MembersYes (true)ElectionOfBoardMembersInd
Decisions Subject To ApprovaYes (true)DecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (true)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (true)MinutesOfCommitteesInd
Officer Mailing AddressfalseOfficerMailingAddressInd
Local ChaptersfalseLocalChaptersInd
Form990 Provided To Gvrn BodyYes (true)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (true)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (true)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (true)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (true)WhistleblowerPolicyInd
Document Retention PolicyYes (true)DocumentRetentionPolicyInd
Compensation Process CEOYes (true)CompensationProcessCEOInd
Compensation Process OtherYes (true)CompensationProcessOtherInd
Investment In Joint VentureYes (true)InvestmentInJointVentureInd
Written Policy Or ProcedureYes (true)WrittenPolicyOrProcedureInd
States Where Copy Of Return Is FldCTStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldFLStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNJStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldOKStatesWhereCopyOfReturnIsFldCd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

FieldValueIRS element (for citing)
PersonNANCY KONGPersonNm
Phone6469777154PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1101 AVENUE OF THE AMERICAS 7TH FLOAddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP10013ZIPCd
FieldValueIRS element (for citing)
Info In Schedule O Part VIIYes (X)InfoInScheduleOPartVIIInd

Form990 Part VII Section A Form990PartVIISectionAGrp (40 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtAverage Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtOfficerOfficerIndKey EmployeeKeyEmployeeIndHighest Compensated EmployeeHighestCompensatedEmployeeIndFormer Ofcr Director TrusteeFormerOfcrDirectorTrusteeInd
DAFNA BAR-SAGI PHD
DIRECTOR1.00.0Yes (X)$0$0$0
RUSSELL L CARSON MBA
DIRECTOR & CO-CHAIR4.00.0Yes (X)$0$0$0Yes (X)
DENNIS S CHARNEY MD
DIRECTOR1.00.0Yes (X)$0$0$0
AUGUSTINE MK CHOI MD
DIRECTOR1.00.0Yes (X)$0$0$0
NICHOLAS DONOFRIO
DIRECTOR1.00.0Yes (X)$0$0$0
JOHN B EHRENKRANZ
DIRECTOR1.00.0Yes (X)$0$0$0
ANTHONY B EVNIN PHD
DIRECTOR1.00.0Yes (X)$0$0$0
WILLIAM E FORD
DIRECTOR - THRU 02/04/171.00.0Yes (X)$0$0$0
LEE GOLDMAN MD MPH
DIRECTOR1.00.0Yes (X)$0$0$0
JOHN HAVENS
DIRECTOR1.00.0Yes (X)$0$0$0
WESLIE R JANEWAY
DIRECTOR1.00.0Yes (X)$0$0$0
RICHARD P LIFTON MD PHD
DIRECTOR1.00.0Yes (X)$0$0$0
EDISON T LIU MD
DIRECTOR1.00.0Yes (X)$0$0$0
HERB PARDES MD
DIRECTOR & VICE CHAIR1.00.0Yes (X)$0$0$0
FRANK E RICHARDSON MA JD
DIRECTOR1.00.0Yes (X)$0$0$0
ARTHUR J SAMBERG
DIRECTOR - THRU 03/24/171.00.0Yes (X)$0$0$0
IVAN G SEIDENBERG MBA
DIRECTOR & CO-CHAIR4.00.0Yes (X)$0$0$0Yes (X)
FRANK V SICA
DIRECTOR / COMMITTEE CHAIR1.00.0Yes (X)$0$0$0
JIM SIMONS PHD
DIRECTOR1.00.0Yes (X)$0$0$0
STEVEN SINGER ESQ
DIRECTOR1.00.0Yes (X)$0$0$0
ALLEN M SPIEGEL MD
DIRECTOR1.00.0Yes (X)$0$0$0
SAMUEL L STANLEY JR MD
DIRECTOR1.00.0Yes (X)$0$0$0
BRUCE STILLMAN PHD
DIRECTOR1.00.0Yes (X)$0$0$0
CRAIG B THOMPSON MD
DIRECTOR1.00.0Yes (X)$0$0$0
KEVIN J TRACEY MD
DIRECTOR1.00.0Yes (X)$0$0$0
TOM MANIATIS PhD
DIRECTOR - INTERIM S.D. & CEO40.00.0Yes (X)$0$0$0Yes (X)
CHERYL A MOORE
PRESIDENT & COO40.00.0Yes (X)$1,167,309$0$216,998Yes (X)
CHRIS DUIGNAN
VP, FINANCE40.00.0$313,374$0$42,287Yes (X)
ELIZABETH O'BRIEN
VICE PRESIDENT & GEN. COUNSEL40.00.0$415,722$0$42,514Yes (X)
CAROL ASHE
CHIEF BUSINESS OFFICER40.00.0$451,089$0$13,617Yes (X)
HAROLD SWERDLOW PHD
VP OF SEQUENCING-THRU 11/30/1740.00.0$411,959$0$28,719Yes (X)
KATHLEEN MCGOVERN KEARNS
VICE PRESIDENT, DEV'T & COMM40.00.0$411,085$0$27,165Yes (X)
TOBY BLOOM PHD
DEPUTY SCIENTIFIC DIR., INFO.40.00.0$364,761$0$30,270Yes (X)
MATTHEW J PELO
VP, FINANCIAL STRATEGY & OPS40.00.0$322,954$0$21,614Yes (X)
SHAILAJA GARGEYA
SENIOR DIR. SOFTWARE ENGINEER40.00.0$292,967$0$35,830Yes (X)
DAYNA M OSCHWALD
SNR. DIR, INFO. PGM MGMT40.00.0$233,308$0$23,307Yes (X)
SOREN GERMER PhD
DIRECTOR SEQUENCING OPERATIONS40.00.0$205,308$0$25,788Yes (X)
TERRY DOUGLAS DONTJE
SR PRINCIPAL, SOFWARE ENGINEER40.00.0$190,767$0$37,156Yes (X)
CHRISTOPHER BLACK
Director, Research Computing40.00.0$192,304$0$27,715Yes (X)
ROBERT B DARNELL MD PHD
FOUNDING DIR&CEO-THRU 12/31/160.00.0$463,672$0$0Yes (X)
FieldValueIRS element (for citing)
Total Reportable Comp From Org$5,436,579TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$0TotReportableCompRltdOrgAmt
Total Other Compensation$572,980TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K87IndivRcvdGreaterThan100KCnt
Former Ofcr Employees ListedYes (true)FormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (true)TotalCompGreaterThan150KInd
Compensation From Other SrcsfalseCompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (5 entries)

Address Line1ContractorAddress/USAddress/AddressLine1TxtCityContractorAddress/USAddress/CityNmState AbbreviationContractorAddress/USAddress/StateAbbreviationCdZIPContractorAddress/USAddress/ZIPCdServicesServicesDescCompensationCompensationAmt
Alvarez Marsal Heathcare Industry
600 MADISON AVENUE 8TH FLNEW YORKNY10022Consulting Services$1,490,424
PJ Mechanical Service Maintenanc
55 BROAD STREETNEW YORKNY10004Engineering Services$612,442
Gensler
PO BOX 848279DALLASTX75284Architect Services$555,112
Robert Darnell MD PhD
236 ELDERWOOD AVEPELHAMNY10803Management Services$463,672
Guardian Service Industries Inc
88005 EXPEDITE WAYCHICAGOIL60695Cleaning Services$246,979
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K15CntrctRcvdGreaterThan100KCnt
Membership Dues$3,035,000MembershipDuesAmt
Government Grants$21,583,627GovernmentGrantsAmt
All Other Contributions$46,104,587AllOtherContributionsAmt
Total Contributions$70,723,214TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp (3 entries)

DescDescBusinessBusinessCdTotal Revenue ColumnTotalRevenueColumnAmtRelated Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmtUnrelated Business RevenueUnrelatedBusinessRevenueAmt
RESEARCH SEQUENCING541700$14,844,068$13,988,625$855,443
RESEARCH541700$2,350,599$2,350,599
CLINICAL SEQUENCING541700$6,521,931$6,521,931
FieldValueIRS element (for citing)
Total Program Service Revenue$23,716,598TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$88,421TotalRevenueColumnAmt
Exclusion$88,421ExclusionAmt

Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Royalties Revenue RoyaltiesRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Gross Rents GrossRentsGrp

FieldValueIRS element (for citing)
Real$290,304RealAmt

Less Rental Expenses LessRentalExpensesGrp

FieldValueIRS element (for citing)
Real$290,304RealAmt

Rental Income Or Loss RentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Real$0RealAmt
Personal$0PersonalAmt

Net Rental Income Or Loss NetRentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt
FieldValueIRS element (for citing)
Fundraising Gross Income$0FundraisingGrossIncomeAmt
Fundraising Direct Expenses$0FundraisingDirectExpensesAmt

Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt
FieldValueIRS element (for citing)
Gaming Gross Income$0GamingGrossIncomeAmt
Gaming Direct Expenses$0GamingDirectExpensesAmt

Net Income From Gaming NetIncomeFromGamingGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt
FieldValueIRS element (for citing)
Gross Sales Of Inventory$0GrossSalesOfInventoryAmt
Cost Of Goods Sold$0CostOfGoodsSoldAmt

Net Income Or Loss NetIncomeOrLossGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Other Revenue Misc OtherRevenueMiscGrp (2 entries)

DescDescBusinessBusinessCdTotal Revenue ColumnTotalRevenueColumnAmtExclusionExclusionAmt
EVENT SPACE REVENUE900099$46,500$46,500
OTHER REVENUE900099$48,799$48,799
FieldValueIRS element (for citing)
Other Revenue Total$95,299OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$94,623,532TotalRevenueColumnAmt
Related Or Exempt Func Income$22,861,155RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$855,443UnrelatedBusinessRevenueAmt
Exclusion$183,720ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$991,540TotalAmt
Program Services$991,540ProgramServicesAmt

Grants To Domestic Individuals GrantsToDomesticIndividualsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Foreign Grants ForeignGrantsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Benefits To Members BenefitsToMembersGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$4,262,038TotalAmt
Program Services$2,991,523ProgramServicesAmt
Management And General$1,153,675ManagementAndGeneralAmt
Fundraising$116,840FundraisingAmt

Comp Disqual Persons CompDisqualPersonsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$20,100,598TotalAmt
Program Services$14,108,603ProgramServicesAmt
Management And General$5,440,954ManagementAndGeneralAmt
Fundraising$551,041FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$1,099,529TotalAmt
Program Services$771,759ProgramServicesAmt
Management And General$297,627ManagementAndGeneralAmt
Fundraising$30,143FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$2,903,405TotalAmt
Program Services$2,037,899ProgramServicesAmt
Management And General$785,912ManagementAndGeneralAmt
Fundraising$79,594FundraisingAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$1,792,350TotalAmt
Program Services$1,258,050ProgramServicesAmt
Management And General$485,164ManagementAndGeneralAmt
Fundraising$49,136FundraisingAmt

Fees For Services Management FeesForServicesManagementGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$475,009TotalAmt
Program Services$2,978ProgramServicesAmt
Management And General$472,031ManagementAndGeneralAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$174,361TotalAmt
Management And General$174,361ManagementAndGeneralAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

FieldValueIRS element (for citing)
Total$92,427TotalAmt
Management And General$92,427ManagementAndGeneralAmt

Fees For Services Prof Fundraising FeesForServicesProfFundraising

FieldValueIRS element (for citing)
Total$140,000TotalAmt
Fundraising$140,000FundraisingAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$3,864,596TotalAmt
Program Services$2,700,538ProgramServicesAmt
Management And General$1,164,058ManagementAndGeneralAmt

Advertising AdvertisingGrp

FieldValueIRS element (for citing)
Total$91,267TotalAmt
Program Services$12,079ProgramServicesAmt
Management And General$76,406ManagementAndGeneralAmt
Fundraising$2,782FundraisingAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$773,196TotalAmt
Program Services$169,011ProgramServicesAmt
Management And General$602,727ManagementAndGeneralAmt
Fundraising$1,458FundraisingAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$2,388,766TotalAmt
Program Services$1,541,632ProgramServicesAmt
Management And General$846,067ManagementAndGeneralAmt
Fundraising$1,067FundraisingAmt

Royalties RoyaltiesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$15,799,205TotalAmt
Program Services$10,459,924ProgramServicesAmt
Management And General$5,160,520ManagementAndGeneralAmt
Fundraising$178,761FundraisingAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$367,132TotalAmt
Program Services$228,667ProgramServicesAmt
Management And General$134,969ManagementAndGeneralAmt
Fundraising$3,496FundraisingAmt

Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$216,512TotalAmt
Program Services$108,285ProgramServicesAmt
Management And General$95,427ManagementAndGeneralAmt
Fundraising$12,800FundraisingAmt

Interest InterestGrp

FieldValueIRS element (for citing)
Total$923,295TotalAmt
Program Services$696,511ProgramServicesAmt
Management And General$215,027ManagementAndGeneralAmt
Fundraising$11,757FundraisingAmt

Payments To Affiliates PaymentsToAffiliatesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$13,063,480TotalAmt
Program Services$7,501,956ProgramServicesAmt
Management And General$5,516,661ManagementAndGeneralAmt
Fundraising$44,863FundraisingAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$401,672TotalAmt
Management And General$401,672ManagementAndGeneralAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDescTotalTotalAmtProgram ServicesProgramServicesAmtManagement And GeneralManagementAndGeneralAmtFundraisingFundraisingAmt
DIRECT COST OF SEQUENCING$17,383,671$17,383,671
RESEARCH & CLIA$4,693,506$4,693,506
RECRUITMENT$156,024$76,822$79,202
ALL OTHER EXPENSE$132,296$112,113$12,799$7,384

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$92,285,875TotalAmt
Program Services$67,847,067ProgramServicesAmt
Management And General$23,207,686ManagementAndGeneralAmt
Fundraising$1,231,122FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$15,120,314BOYAmt
EOY$6,415,091EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

FieldValueIRS element (for citing)
BOY$19,131,071BOYAmt
EOY$18,053,451EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$6,687,337BOYAmt
EOY$8,882,349EOYAmt

Receivables From Officers Etc ReceivablesFromOfficersEtcGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Inventories For Sale Or Use InventoriesForSaleOrUseGrp

FieldValueIRS element (for citing)
BOY$7,515,459BOYAmt
EOY$4,494,873EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$2,375,799BOYAmt
EOY$4,164,286EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$114,501,839LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$53,961,882LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$59,917,403BOYAmt
EOY$60,539,957EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Investments Program Related InvestmentsProgramRelatedGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Intangible Assets IntangibleAssetsGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Other Assets Total OtherAssetsTotalGrp

FieldValueIRS element (for citing)
BOY$11,323,522BOYAmt
EOY$11,646,268EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$122,070,905BOYAmt
EOY$114,196,275EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$14,754,579BOYAmt
EOY$9,332,329EOYAmt

Grants Payable GrantsPayableGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Deferred Revenue DeferredRevenueGrp

FieldValueIRS element (for citing)
BOY$13,596,240BOYAmt
EOY$4,647,997EOYAmt

Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Escrow Account Liability EscrowAccountLiabilityGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Loans From Officers Directors LoansFromOfficersDirectorsGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp

FieldValueIRS element (for citing)
BOY$5,543,160BOYAmt
EOY$7,013,580EOYAmt

Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp

FieldValueIRS element (for citing)
BOY$21,885,110BOYAmt
EOY$24,633,098EOYAmt

Other Liabilities OtherLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$27,090,658BOYAmt
EOY$27,030,456EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$82,869,747BOYAmt
EOY$72,657,460EOYAmt
FieldValueIRS element (for citing)
Organization Follows SFAS117Yes (X)OrganizationFollowsSFAS117Ind

Unrestricted Net Assets UnrestrictedNetAssetsGrp

FieldValueIRS element (for citing)
BOY$17,485,267BOYAmt
EOY$22,459,118EOYAmt

Temporarily Rstr Net Assets TemporarilyRstrNetAssetsGrp

FieldValueIRS element (for citing)
BOY$21,715,891BOYAmt
EOY$19,079,697EOYAmt

Permanently Rstr Net Assets PermanentlyRstrNetAssetsGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$39,201,158BOYAmt
EOY$41,538,815EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$122,070,905BOYAmt
EOY$114,196,275EOYAmt
FieldValueIRS element (for citing)
Reconcilation Revenue Expnss$2,337,657ReconcilationRevenueExpnssAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or ReviewfalseAccountantCompileOrReviewInd
FS AuditedYes (true)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Separate Basis Fincl StmtYes (X)SeparateBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (true)AuditCommitteeInd
Federal Grant Audit RequiredYes (true)FederalGrantAuditRequiredInd
Federal Grant Audit PerformedYes (true)FederalGrantAuditPerformedInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Public Organization170Yes (X)PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$14,419,687CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$52,034,400CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$61,060,764CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$94,901,046CurrentTaxYearMinus1YearAmt
Current Tax Year$70,723,214CurrentTaxYearAmt
Total$293,139,111TotalAmt

Tax Rev Levied Orgnztnl Bnft170 TaxRevLeviedOrgnztnlBnft170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Govt Furn Srvc Fclts Vl170 GovtFurnSrvcFcltsVl170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$14,419,687CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$52,034,400CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$61,060,764CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$94,901,046CurrentTaxYearMinus1YearAmt
Current Tax Year$70,723,214CurrentTaxYearAmt
Total$293,139,111TotalAmt
FieldValueIRS element (for citing)
Substantial Contributors Tot$96,058,584SubstantialContributorsTotAmt
Public Support Total170$197,080,527PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$83,412CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$556,550CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$268,801CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$302,728CurrentTaxYearMinus1YearAmt
Current Tax Year$378,725CurrentTaxYearAmt
Total$1,590,216TotalAmt

Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Other Income170 OtherIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus2 Years$116,870CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$58,024CurrentTaxYearMinus1YearAmt
Current Tax Year$95,299CurrentTaxYearAmt
Total$270,193TotalAmt
FieldValueIRS element (for citing)
Total Support$294,999,520TotalSupportAmt
Gross Receipts Rltd Activities$90,418,270GrossReceiptsRltdActivitiesAmt
Public Support CY1700.66807PublicSupportCY170Pct
Public Support PY1700.70161PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170Yes (X)ThirtyThrPctSuprtTestsCY170Ind

Schedule B IRS990ScheduleB

Schedule C IRS990ScheduleC

FieldValueIRS element (for citing)
Total Grassroots LobbyingTotalGrassrootsLobbyingGrp
Total Direct LobbyingTotalDirectLobbyingGrp
Total Lobbying ExpendTotalLobbyingExpendGrp
Other Exempt Purpose ExpendOtherExemptPurposeExpendGrp
Total Exempt Purpose ExpendTotalExemptPurposeExpendGrp
Lobbying Nontaxable AmountLobbyingNontaxableAmountGrp
Grassroots NontaxableGrassrootsNontaxableGrp
Tot Lbbyng Grassroot Mns Non TxTotLbbyngGrassrootMnsNonTxGrp
Tot Lbby Expend Mns Lbbyng Non TxTotLbbyExpendMnsLbbyngNonTxGrp
VolunteersfalseVolunteersInd
Paid Staff Or ManagementYes (true)PaidStaffOrManagementInd
Media AdvertisementsfalseMediaAdvertisementsInd
Mailings MembersfalseMailingsMembersInd
Publications Or BroadcastfalsePublicationsOrBroadcastInd
Grants Other OrganizationsfalseGrantsOtherOrganizationsInd
Direct Contact LegislatorsYes (true)DirectContactLegislatorsInd
Direct Contact Legislators$3,500DirectContactLegislatorsAmt
Rallies DemonstrationsfalseRalliesDemonstrationsInd
Other ActivitiesYes (true)OtherActivitiesInd
Other Activities$92,427OtherActivitiesAmt
Total Lobbying Expenditures$95,927TotalLobbyingExpendituresAmt
Not Described Section501c3falseNotDescribedSection501c3Ind

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceLOBBYING ACTIVITIESFormAndLineReferenceDesc
ExplanationSCHEDULE C, PART II-B, LINES 1G & 1I THROUGH ITS LEGISLATIVE CONSULTANTS, NYGC ADVOCATES AT THE STATE AND LOCAL LEVEL FOR GOVERNMENT FUNDS TO SUPPORT CURRENT OPERATIONS AND/OR EXPAND RESEARCH OPPORTUNITIES AT NYGC. NYGC ALSO MAINTAINS MEMBERSHIPS IN SEVERAL IRC SECTION 501(C)(6) ORGANIZATIONS THAT REPRESENT THE INTERESTS OF THE MEDICAL RESEARCH COMMUNITY; $2,427 OF THE DUES THAT NYGC PAID TO THESE ASSOCIATIONS WERE ATTRIBUTABLE TO LOBBYING IN 2017. ADDITIONALLY, NYGC STAFF MAY, FROM TIME TO TIME, CONTACT FEDERAL LEGISLATORS OR THEIR STAFFS TO ENCOURAGE THEIR SUPPORT FOR MATTERS OF CONCERN TO THE ACADEMIC MEDICAL RESEARCH COMMUNITY. SUCH CONTACT MAY INCLUDE WRITING LETTERS OR OCCASIONAL MEETINGS WITH PUBLIC OFFICIALS. THE APPROXIMATE COST ASSOCIATED WITH COMMUNICATIONS WITH CAPITOL HILL IS $3,500.ExplanationTxt

Schedule D IRS990ScheduleD

FieldValueIRS element (for citing)
Art Public Exhibition AmountsArtPublicExhibitionAmountsGrp
Held Works ArtHeldWorksArtGrp
CY Minus3 Yr Endwmt FundCYMinus3YrEndwmtFundGrp
CY Minus4 Yr Endwmt FundCYMinus4YrEndwmtFundGrp
LandLandGrp
BuildingsBuildingsGrp

Leasehold Improvements LeaseholdImprovementsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$53,507,688OtherCostOrOtherBasisAmt
Depreciation$11,826,254DepreciationAmt
Book Value$41,681,434BookValueAmt

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$32,444,083OtherCostOrOtherBasisAmt
Depreciation$24,951,639DepreciationAmt
Book Value$7,492,444BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$28,550,068OtherCostOrOtherBasisAmt
Depreciation$17,183,989DepreciationAmt
Book Value$11,366,079BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$60,539,957TotalBookValueLandBuildingsAmt

Other Assets Org OtherAssetsOrgGrp (2 entries)

DescDescBook ValueBookValueAmt
SECURITY DEPOSITS$11,110,521
DEFERRED COMPENSATION$535,747
FieldValueIRS element (for citing)
Total Book Value Other Assets$11,646,268TotalBookValueOtherAssetsAmt
Federal Income Tax Liability$0FederalIncomeTaxLiabilityAmt

Other Liabilities Org OtherLiabilitiesOrgGrp (2 entries)

DescDescAmtAmt
ACCRUED INTEREST PAYABLE$13,077
DEFERRED RENT$27,017,379
FieldValueIRS element (for citing)
Total Liability$27,030,456TotalLiabilityAmt
Footnote TextYes (X)FootnoteTextInd
Total Rev Etc Audited Fincl Stmt$94,913,836TotalRevEtcAuditedFinclStmtAmt
Revenue Subtotal$94,913,836RevenueSubtotalAmt
Other Revenues Not Included-$290,304OtherRevenuesNotIncludedAmt
Revenue Not Reported Fincl Stmt-$290,304RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990$94,623,532TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt$92,576,179TotExpnsEtcAuditedFinclStmtAmt
Other Expenses Included$290,304OtherExpensesIncludedAmt
Expenses Not Reported$290,304ExpensesNotReportedAmt
Expenses Subtotal$92,285,875ExpensesSubtotalAmt
Total Expenses Per Form990$92,285,875TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
INCOME TAXESSCHEDULE D, PART X, LINE 2 NYGC IS SUBJECT TO THE PROVISIONS OF THE FASB ASC SECTION 740-10-05, INCOME TAXES OVERALL, RELATING TO ACCOUNTING AND REPORTING FOR UNCERTAINTY IN INCOME TAXES. NYGC RECOGNIZES THE EFFECT OF INCOME TAX POSITIONS ONLY IF THOSE POSITIONS ARE MORE LIKELY THAN NOT TO BE SUSTAINED AND HAS DETERMINED IT DID NOT HAVE ANY EXPOSURE TO UNCERTAIN TAX POSITIONS DURING 2017 AND 2016.
REVENUE AND EXPENSE RECONCILIATIONSCHEDULE D, PART XI, LINE 4B AND PART XII, LINE 2D ($290,304) RENTAL EXPENSES ALLOCABLE TO 990, PART VIII

Schedule F IRS990ScheduleF

Account Activities Outside US AccountActivitiesOutsideUSGrp (3 entries)

RegionRegionTxtEmployeeEmployeeCntType Of Activities ConductedTypeOfActivitiesConductedTxtSpecific Services ProvidedSpecificServicesProvidedTxtRegion Total ExpendituresRegionTotalExpendituresAmt
Europe (Including Iceland and Greenland)6Program ServicesRESEARCH$417,871
North America1Program ServicesRESEARCH$27,320
Middle East and North Africa1Program ServicesRESEARCH$22,000
FieldValueIRS element (for citing)
Subtotal Employees8SubtotalEmployeesCnt
Total Employee8TotalEmployeeCnt
Subtotal Spent$467,191SubtotalSpentAmt
Total Spent$467,191TotalSpentAmt
Transfer To Foreign CorpfalseTransferToForeignCorpInd
Interest In Foreign TrustfalseInterestInForeignTrustInd
Foreign Corp OwnershipfalseForeignCorpOwnershipInd
Passive Foreign Investmest CofalsePassiveForeignInvestmestCoInd
Foreign PartnershipfalseForeignPartnershipInd
Boycott CountriesfalseBoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line Referenceaccounting methodFormAndLineReferenceDesc
ExplanationSCHEDULE F, PART I, LINE 3 THE PROGRAM EXPENDITURES ARE REPORTED ON THE ACCRUAL METHOD.ExplanationTxt

Schedule G IRS990ScheduleG

FieldValueIRS element (for citing)
In Person SolicitationsYes (X)InPersonSolicitationsInd
Agrmt Prof Fundraising ActyYes (true)AgrmtProfFundraisingActyInd

Fundraiser Activity Info FundraiserActivityInfoGrp

FieldValueIRS element (for citing)
PersonCOMMUNITY COUNSELLING SERVICEPersonNm
ActivityCAMPAIGN SERVICESActivityTxt
Fundraiser Control Of FundsfalseFundraiserControlOfFundsInd
Gross Receipts$0GrossReceiptsAmt
Retained By Contractor$140,000RetainedByContractorAmt
Net To Organization-$140,000NetToOrganizationAmt
FieldValueIRS element (for citing)
Total Gross Receipts$0TotalGrossReceiptsAmt
Total Retained By Contractors$140,000TotalRetainedByContractorsAmt
Total Net To Organization-$140,000TotalNetToOrganizationAmt
Licensed StatesCTLicensedStatesCd
Licensed StatesFLLicensedStatesCd
Licensed StatesNJLicensedStatesCd
Licensed StatesNYLicensedStatesCd
Licensed StatesOKLicensedStatesCd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceSchedule G, Part I, Line 2bFormAndLineReferenceDesc
ExplanationCOMMUNITY COUNSELLING SERVICE'S ADDRESS: 527 MADISON AVENUE 5TH FLOOR NEW YORK, NY 10022 SCHEDULE G, PART I, LINE 2B, COLUMN (IV) NYGC UTILIZES THE SERVICES OF A FUNDRAISING ADVISOR TO CONSULT ON THE DEVELOPMENT ACTIVITIES OF THE ORGANIZATION. DUE TO THE NATURE OF THESE ARRANGEMENTS, NYGC IS UNABLE TO REASONABLY DETERMINE THE GROSS RECEIPTS FROM THE FUNDRAISING ACTIVITIES WHICH ARE SOLELY ATTRIBUTABLE TO THIS ADVISOR.ExplanationTxt

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Grant Records MaintainedYes (true)GrantRecordsMaintainedInd

Recipient Table RecipientTable (7 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdRecipient EINRecipientEINIRC SectionIRCSectionDescCash GrantCashGrantAmtPurpose Of GrantPurposeOfGrantTxtAddress Line2USAddress/AddressLine2Txt
TRUSTEES OF COLUMBIA UNIVERSITY IN CITY OF NY
630 W 168TH STNEW YORKNY10032135598093501(C)(3)$196,297RESEARCH SUBAWARD
COLD SPRING HARBOR LABORATORY
1 BUNGTOWN RDCOLD SPRING HARBORNY11724112013303501(C)(3)$232,552RESEARCH SUBAWARD
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
ONE GUSTAVE L LEVY PLNEW YORKNY10029136171197501(C)(3)$55,874RESEARCH SUBAWARDBOX 1075
REGENTS OF THE UNIVERSITY OF CALIFORNIA-SF
1550 4TH STREETSAN FRANCISCOCA94158946036493115 - CA$20,816RESEARCH SUBAWARD
REGENTS OF THE UNIVERSITY OF CALIFORNIA-LA
11000 KINROSS AVELOS ANGELESCA90095956006143115 - CA$43,901RESEARCH SUBAWARD
UNIVERSITY OF WASHINGTON
4333 BROOKLYN AVE NESEATTLEWA98195916001537115 - WA$196,282RESEARCH SUBAWARD
THE ROCKEFELLER UNIVERSITY
1230 YORK AVENUENEW YORKNY10064131624158501(C)(3)$245,818RESEARCH SUBAWARD
FieldValueIRS element (for citing)
Total501c3 Org7Total501c3OrgCnt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceMONITORING USE OF GRANT FUNDSFormAndLineReferenceDesc
ExplanationSCHEDULE I, PART I, LINE 2 NYGC MONITORS SUBRECIPIENTS' USE OF GRANT FUNDS IN BOTH THE PRE-AWARD AND POST-AWARD STAGES. IN THE PRE-AWARD PHASE, SUBRECIPIENTS ARE EVALUATED BY NYGC'S SPONSORED RESEARCH AND ACADEMIC/SCIENTIFIC DEPARTMENTS, WITH CONSIDERATION OF SUBRECIPIENT CAPABILITIES AND INFRASTRUCTURE, AS WELL AS THE APPROPRIATE CHECKS FOR SUSPENSION AND DEBARMENT. A SUB-RECIPIENT MONITORING FORM IS SENT TO ALL SUB-AWARDEES AND THIS FORM IS THE BASIS BY WHICH NYGC ASSESSES RISK. IN THE POST-AWARD PHASE, NYGC'S GRANTS ACCOUNTING DEPARTMENT WORKS WITH THE SPONSORED RESEARCH TEAM TO MONITOR PROGRAMMATIC PROGRESS IN A MANNER CONSISTENT WITH THE TERMS AND CONDITIONS OF THE AWARD. NYGC'S FINANCE/GRANTS ACCOUNTING DEPARTMENT REVIEWS ANY SUBRECIPIENT EXPENSES INVOICED TO NYGC FOR ALLOWABILITY WITH REGARD TO RELEVANT COST PRINCIPLES AND BUDGETARY RESTRICTIONS AND PROVIDES SUBRECIPIENT INVOICES TO SPONSORED RESEARCH FOR ITS REVIEW AND APPROVAL. AFTER THE SPONSORED RESEARCH AND FINANCE/GRANTS ACCOUNTING DEPARTMENTS HAVE APPROVED SUBRECIPIENT INVOICES, THE SUBRECIPIENT IS PAID. SUBAWARDS ELIGIBLE FOR FFATA REPORTING ARE RECORDED IN THE FSRS (THE FFATA SUBAWARD REPORTING SYSTEM) IN ACCORDANCE WITH THE FEDERAL REPORTING REQUIREMENTS FOR FIRST-TIER SUBAWARDS UNDER NYGC'S PRIME FEDERAL AWARDS.ExplanationTxt

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Idemnification Gross Up PmtsYes (X)IdemnificationGrossUpPmtsInd
Housing Allowance Or ResidenceYes (X)HousingAllowanceOrResidenceInd
Written Policy Ref T And E ExpnssYes (true)WrittenPolicyRefTAndEExpnssInd
Substantiation RequiredYes (true)SubstantiationRequiredInd
Compensation CommitteeYes (X)CompensationCommitteeInd
Independent ConsultantYes (X)IndependentConsultantInd
Form990 Of Other OrganizationsYes (X)Form990OfOtherOrganizationsInd
Compensation SurveyYes (X)CompensationSurveyInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance PaymentfalseSeverancePaymentInd
Supplemental Nonqual Rtr PlanYes (true)SupplementalNonqualRtrPlanInd
Equity Based Comp ArrngmfalseEquityBasedCompArrngmInd
Comp Based On Revenue Of Flng OrgfalseCompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related OrgsfalseCompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng OrgfalseCompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd OrgsfalseCompBsdNetEarnsRltdOrgsInd
Any Non Fixed PaymentsfalseAnyNonFixedPaymentsInd
Initial Contract ExceptionfalseInitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (14 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
ROBERT B DARNELL MD PHD
FOUNDING DIR&CEO-THRU 12/31/16$136,374$0$0$0$327,298$0$0$0$0$0$463,672$0$0$0
CHERYL A MOORE
PRESIDENT & COO$897,254$0$0$0$270,055$0$213,500$0$3,498$0$1,384,307$0$0$0
CHRIS DUIGNAN
VP, FINANCE$313,374$0$0$0$0$0$12,948$0$29,339$0$355,661$0$0$0
CAROL ASHE
CHIEF BUSINESS OFFICER$431,599$0$0$0$19,490$0$13,500$0$117$0$464,706$0$0$0
HAROLD SWERDLOW PHD
VP OF SEQUENCING-THRU 11/30/17$387,121$0$0$0$24,838$0$13,500$0$15,219$0$440,678$0$0$0
KATHLEEN MCGOVERN KEARNS
VICE PRESIDENT, DEV'T & COMM$391,973$0$0$0$19,112$0$10,395$0$16,770$0$438,250$0$0$0
TOBY BLOOM PHD
DEPUTY SCIENTIFIC DIR., INFO.$364,761$0$0$0$0$0$13,500$0$16,770$0$395,031$0$0$0
MATTHEW J PELO
VP, FINANCIAL STRATEGY & OPS$322,954$0$0$0$0$0$12,899$0$8,715$0$344,568$0$0$0
ELIZABETH O'BRIEN
VICE PRESIDENT & GEN. COUNSEL$379,925$0$0$0$35,797$0$13,926$0$28,588$0$458,236$0$0$0
SHAILAJA GARGEYA
SENIOR DIR. SOFTWARE ENGINEER$292,967$0$0$0$0$0$13,500$0$22,330$0$328,797$0$0$0
DAYNA M OSCHWALD
SNR. DIR, INFO. PGM MGMT$233,308$0$0$0$0$0$7,661$0$15,646$0$256,615$0$0$0
SOREN GERMER PhD
DIRECTOR SEQUENCING OPERATIONS$205,308$0$0$0$0$0$10,444$0$15,344$0$231,096$0$0$0
TERRY DOUGLAS DONTJE
SR PRINCIPAL, SOFWARE ENGINEER$190,767$0$0$0$0$0$9,948$0$27,208$0$227,923$0$0$0
CHRISTOPHER BLACK
Director, Research Computing$192,304$0$0$0$0$0$9,865$0$17,850$0$220,019$0$0$0

Supplemental Information Detail SupplementalInformationDetail (3 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
SCHEDULE J, PART I, LINE 1TAX INDEMNIFICATION AND GROSS-UP PAYMENTS NYGC PROVIDED TUITION ASSISTANCE FOR A FAMILY MEMBER OF THE VICE PRESIDENT AND GENERAL COUNSEL. THE VALUE OF THIS ASSISTANCE WAS TREATED AS COMPENSATION TO THE EMPLOYEE FOR WHICH NYGC MADE GROSS-UP PAYMENTS TO ALLEVIATE THE TAX BURDEN ON THE EMPLOYEE. HOUSING ALLOWANCE OR RESIDENCE FOR PERSONAL USE NYGC PROVIDED A HOUSING ALLOWANCE TO THE PRESIDENT AND COO. THE VALUE OF THIS ASSISTANCE WAS TREATED AS TAXABLE COMPENSATION TO THE EMPLOYEE. NYGC SELECTIVELY OFFERS HOUSING ALLOWANCES TO EMPLOYEES, PRINCIPALLY AS A RECRUITING TOOL FOR NEW FACULTY AND POSTDOCTORAL FELLOWS. SUBSIDIZED HOUSING OR HOUSING ALLOWANCES ARE COMMONLY OFFERED BY PEER ACADEMIC INSTITUTIONS IN NEW YORK CITY TO HELP FACULTY AND OTHER RESEARCHERS DEFRAY THE HIGH COST OF HOUSING.
EXECUTIVE COMPENSATIONSCHEDULE J, PART I, LINE 3 AT THE TIME OF HIRE, AN AD-HOC EXECUTIVE COMPENSATION COMMITTEE COMPRISED OF INDEPENDENT BOARD MEMBERS (THE "AD-HOC COMMITTEE") WAS RESPONSIBLE FOR ESTABLISHING THE PRESIDENT AND COOS COMPENSATION PACKAGE AND THE TERMS OF HER EMPLOYMENT CONTRACT. HER COMPENSATION WAS DETERMINED THROUGH A REVIEW OF FORM 990 RETURNS AND COMPENSATION INFORMATION FOR TOP MANAGEMENT OFFICIALS AT SIMILARLY SITUATED ORGANIZATIONS OBTAINED THROUGH THE RECRUITING PROCESS. CONSIDERATION ALSO WAS GIVEN TO HER THEN-CURRENT COMPENSATION. ON RECOMMENDATION OF THE AD-HOC COMMITTEE, THE BOARD OF DIRECTORS APPROVED HER COMPENSATION. THIS APPROVAL WAS MEMORALIZED IN THE BOARD MINUTES. THE "INITIAL CONTRACT" EXCEPTION APPLIED FOR 2016 AND HER COMPENSATION HAS NOT CHANGED SINCE SHE JOINED NYGC. IN LATE 2016, NYGC HIRED AN INDEPENDENT COMPENSATION CONSULTANT TO REVIEW THE COMPENSATION PAID TO SENIOR MANAGEMENT. IN EARLY 2017, THE RESULTS OF THIS REVIEW WERE PROVIDED TO THE AD-HOC EXECUTIVE COMPENSATION COMMITTEE COMPRISED OF INDEPENDENT BOARD MEMBERS. THE REVIEW SHOWED THAT THE COMPENSATION PAID TO ALL MEMBERS OF EXECUTIVE AND SENIOR MANAGEMENT WAS REASONABLE AND THIS WAS MEMORALIZED IN THE AD-HOC COMMITTEE'S MINUTES.
SUPPLEMENTAL NONQUALIFIED RETIREMENT PLANSCHEDULE J, PART I, LINE 4B NYGC HAS A DEFERRED COMPENSATION PLAN FOR THE PRESIDENT AND COO. $200,000 WAS DEFERRED IN 2017.

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (10 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
THE ORGANIZATIONS MISSIONFORM 990, PART I, LINE 1 & PART III, LINE 1: THE NEW YORK GENOME CENTER (NYGC) IS ORGANIZED AND OPERATED AS AN INDEPENDENT, NON-PROFIT CORPORATION, DEDICATED TO STATE-OF-THE-ART, WORLD CLASS GENOMIC RESEARCH, SEQUENCING AND BIOINFORMATICS, WHOSE MEMBERS INCLUDE LEADING ACADEMIC, MEDICAL AND RESEARCH INSTITUTIONS. NYGC HAS THE FOLLOWING KEY OBJECTIVES: (I) FOSTERING INTELLECTUALLY VIBRANT RESEARCH COLLABORATIONS IN THE ACADEMIC AND SCIENTIFIC COMMUNITY IN NEW YORK CITY; (II) RECRUITING AND RETAINING WORLD CLASS SCIENTIFIC TALENT TO LEAD THE SCIENTIFIC DEVELOPMENT OF THE ORGANIZATION; (III) SUPPORTING RESEARCH CONDUCTED BY THE INSTITUTIONAL FOUNDING MEMBERS, OTHER ACADEMIC, RESEARCH AND MEDICAL INSTITUTIONS AND THE BIOTECHNOLOGY/PHARMACEUTICAL INDUSTRY TO ADVANCE NYGCS SCIENTIFIC PROGRAM AND GENOMIC RESEARCH; (IV) DEVELOPING ADVANCED BIOINFORMATICS CAPABILITIES BASED UPON THE RESEARCH AND SEQUENCING ACTIVITIES CONDUCTED AT THE ORGANIZATIONS FACILITIES; (V) ADVANCING RESEARCH TO SUPPORT THE DEVELOPMENT OF NEW TREATMENTS, THERAPIES AND THERAPEUTICS TO TREAT HUMAN DISEASE; (VI) PROVIDING TRAINING TO THE ACADEMIC, RESEARCH AND TECHNOLOGY COMMUNITIES; AND (VII) CONDUCTING ACTIVITIES ANCILLARY TO THESE OBJECTIVES.
PROGRAM SERVICE ACCOMPLISHMENTSFORM 990, PART III, LINE 4A, LINE 4B, LINE 4C NYGC IS AN INDEPENDENT, NONPROFIT ACADEMIC RESEARCH INSTITUTION WITH THE MISSION OF ADVANCING CLINICAL CARE THROUGH TRANSFORMATIVE GENOMIC RESEARCH. NYGCS WORK BUILDS ON THE STRENGTHS AND CAPABILITIES THAT THE CENTER HAS DEVELOPED SINCE ITS FOUNDING IN 2010 AND AUGMENTS RESEARCH BEING CONDUCTED BY NYGC MEMBER INSTITUTIONS. COLLABORATING WITH PREMIER ACADEMIC, MEDICAL AND INDUSTRY LEADERS ACROSS THE GLOBE, NYGC IS CONDUCTING DISEASE-BASED GENOMIC RESEARCH IN AREAS WHERE IT HAS DEVELOPED A SIGNIFICANT AND SUCCESSFUL TRACK RECORD, INCLUDING NEURODEGENERATIVE DISEASES SUCH AS ALS, NEUROPSYCHIATRIC DISEASES, PARTICULARLY AUTISM, AND CANCER, AMONG OTHERS. THROUGH GROUNDBREAKING RESEARCH, NYGCS GOAL IS TO ADVANCE THE DEVELOPMENT OF NEW TREATMENTS, THERAPIES AND THERAPEUTICS THAT TREAT HUMAN DISEASE. NYGC AND ITS MEMBER INSTITUTIONS AND PARTNERS ARE UNITED IN THIS UNPRECEDENTED COLLABORATION OF TECHNOLOGY, SCIENCE AND MEDICINE, DESIGNED TO HARNESS THE POWER OF INNOVATION AND DISCOVERIES TO ADVANCE GENOMIC DISCOVERIES. THEIR SHARED OBJECTIVE IS THE ACCELERATION OF MEDICAL GENOMICS AND PRECISION MEDICINE TO BENEFIT PATIENTS AROUND THE WORLD. NYGCS INNOVATION, RESEARCH AND QUALITY MAKE IT A UNIQUE AND STRONG COLLABORATIVE PARTNER. 2017 WAS A PIVOTAL YEAR FOR NYGC, POSITIONING THE ORGANIZATION FOR ITS NEXT PHASE OF GROWTH. NYGCS AWARD-WINNING FACULTY AND STAFF SCIENTISTS ARE PERFORMING THE HIGHEST QUALITY BIOINFORMATICS ANALYSIS AND DEVELOPING INNOVATIVE OPEN-SOURCE GENOMICS METHODS AND TOOLS TO SHARE WITH THE SCIENTIFIC COMMUNITY. THEY ARE LEADING THE WAY IN SINGLE-CELL ANALYSIS, GENE EDITING AND EXPLORATION OF THE NON-CODING AREA OF THE HUMAN GENOME ALL PROMISING FRONTIERS OF GENOMIC RESEARCH. IN 2017, NYGC ESTABLISHED A NEW AFFILIATE MEMBERSHIP PROGRAM, OPEN TO ALL EXTERNAL ACADEMIC RESEARCHERS, TO FURTHER ENCOURAGE THE EXCHANGE OF IDEAS AND FACILITATE MORE COLLABORATIONS. RESEARCH SEQUENCING NYGC HAS ONE OF THE LARGEST VOLUME WHOLE GENOME SEQUENCING PROGRAMS IN NEW YORK. IN THE LAST FIVE YEARS, NYGCS SEQUENCING LABORATORY HAS SEQUENCED TENS OF THOUSANDS OF WHOLE GENOME SAMPLES. IN 2017, THE CENTER ACQUIRED NOVASEQ SYSTEMS SEQUENCERS TO SUPPLEMENT ITS STABLE OF HISEQ X AND 2500 SEQUENCERS. THIS STATE-OF-THE-ART SEQUENCING TECHNOLOGY ENABLES NYGC TO CONDUCT LARGE-SCALE GENOMICS PROJECTS WITH GREATER SPEED AND SAMPLE VOLUMES, AND TO EXPLORE THE GENOME IN MORE DEPTH WITH GREATER EFFICIENCY.
RESEARCH AND FACULTYSINCE ITS INCEPTION, NYGC HAS ATTRACTED WORLD-CLASS SCIENTISTS WHOSE GENOMIC EXPERTISE INCLUDING SINGLE CELL GENOMICS, GENOME ENGINEERING, POPULATION AND EVOLUTIONARY GENOMICS, TECHNOLOGY AND METHODS DEVELOPMENT, STATISTICS, COMPUTATIONAL BIOLOGY AND BIOENGINEERING BRINGS A MULTIDISCIPLINARY AND IN-DEPTH APPROACH TO THE EVOLVING FIELD OF GENOMICS. NYGCS FACULTY SUPPORT THE SCIENTIFIC VISION OF THE CENTER THROUGH THE ADVANCEMENT OF GENOMIC MEDICINE. TO ENHANCE COLLABORATION, FACULTY MEMBERS HAVE JOINT APPOINTMENTS AT OUR INSTITUTIONAL FOUNDING MEMBERS TO STRENGTHEN OUR RESEARCH CAPABILITIES, ADVANCE ACADEMIC LEADERSHIP, AND ENHANCE THEIR ABILITY TO HELP SOLVE HUMAN DISEASES. OVER THE COURSE OF 2017, NYGC MANAGED 37 ACTIVE GRANTS, INCLUDING 22 GRANTS FROM THE NATIONAL INSTITUTES OF HEALTH (NIH). NYGCS RESEARCHERS ARE WORKING WITH ITS MEMBER INSTITUTIONS AND AN ARRAY OF COLLABORATIVE PARTNERS TO ADDRESS THE FUNDAMENTAL CHALLENGE IN PRECISION MEDICINE: UNDERSTANDING THE RELATIONSHIP BETWEEN DNA SEQUENCE VARIATION AND MECHANISMS FOR HUMAN DISEASES, RANGING FROM CANCER TO AUTISM AND NEURODEGENERATIVE DISEASE. NYGC RESEARCHERS PUBLISHED MORE THAN 50 STUDIES IN LEADING SCIENTIFIC JOURNALS IN 2017, FUELING MOMENTUM FOR IMPORTANT COLLABORATIVE WORK. THEY COMPLETED MORE THAN 780 PROJECTS, COLLABORATING WITH 190 INVESTIGATORS FROM 110 INSTITUTIONS ACROSS THE GLOBE. OUR CENTER FOR GENOMICS OF NEURODEGENERATIVE DISEASES ALS CONSORTIUM, LED BY HEMALI PHATNANI, PHD, HAD AT THE END OF 2017 26 MEMBERS FROM LEADING INSTITUTIONS AROUND THE WORLD. SCIENTISTS AND CLINICIANS WORK COLLABORATIVELY TO APPLY STATE-OF-THE-ART CLINICAL AND FUNCTIONAL GENOMICS TOGETHER WITH BIOINFORMATICS TO STUDY ALS DISEASE MECHANISMS AND BETTER UNDERSTAND HOW MUTATIONS UNDERLYING ALS CAUSE DISEASE. THE TARGET OF THIS GLOBAL MULTIDISCIPLINARY EFFORT IS WHOLE GENOME SEQUENCING AND ANALYSIS OF 5,000 CLINICALLY WELL-ANNOTATED ALS SAMPLES BY 2021 TO ENHANCE EARLY DIAGNOSIS AND EFFECTIVE DRUG DISCOVERY. TO ADVANCE COLLABORATIVE EFFORTS ON CANCER GENOMICS, NOBEL LAUREATE HAROLD VARMUS, MD, SENIOR ASSOCIATE CORE MEMBER, NYGC, AND LEWIS THOMAS UNIVERSITY PROFESSOR OF MEDICINE, WEILL CORNELL MEDICINE, ESTABLISHED THE NEW YORK CANCER GENOMICS RESEARCH NETWORK. IN 2017, DR. VARMUS CONVENED MONTHLY MEETINGS AT NYGC WITH LEADING CANCER RESEARCHERS AND CLINICIANS FROM NYGCS INSTITUTIONAL FOUNDING MEMBERS AND OTHER KEY ACADEMIC INSTITUTIONS FROM AROUND THE WORLD. THE OBJECTIVE OF THIS MULTIDISCIPLINARY APPROACH WAS TO HELP SET CRITICAL PRIORITIES IN TRANSLATING GENOMIC SCIENCE INTO MORE EFFECTIVE TREATMENT OPTIONS FOR ALL CANCER PATIENTS IN NEW YORK AND BEYOND. THE CONSORTIUM INITIATED A CITY-WIDE PROJECT TO ENSURE THAT ADVANCES IN GENOMICS AND PRECISION MEDICINE CAN BE APPLIED TO ALL POPULATIONS AND EXPAND KNOWLEDGE OF THE GENETIC VARIATIONS THAT CONTRIBUTE TO CANCER. NAMED THE "POLYETHNIC-1000", THE PROJECT PLANS TO UTILIZE THE GREATER NEW YORK AREAS ETHNIC DIVERSITY TO ADDRESS SEVERAL IMPORTANT SCIENTIFIC QUESTIONS ABOUT THE ROLE OF ETHNICITY IN ONCOLOGY AND OFFER GENOMIC SERVICES DURING THE PROVISION OF CANCER CARE TO ALL POPULATIONS. THIS INITIATIVE WILL INVOLVE PATIENTS AND STAFF AT SEVERAL ACADEMIC HEALTH CENTERS AND PARTNER HOSPITALS IN THE NEW YORK CITY REGION AND WILL USE NYGCS GENOMICS AND INFORMATICS CAPABILITIES TO DETERMINE HOW INHERITED AND ACQUIRED GENETIC VARIATIONS AFFECT THE BEHAVIOR OF DIFFERENT CANCERS OCCURRING IN ETHNICALLY DIVERSE POPULATIONS. IN EARLY 2017, A STUDY BY NYGC CORE FACULTY MEMBER MARCIN IMIELINSKI, MD, PHD PUBLISHED IN CELL ILLUMINATED A POSSIBLE NEW TYPE OF DRIVER OF CANCER: SMALL (ONE- TO 50-LETTER) INSERTIONS OR DELETIONS OF DNA SEQUENCE, ALSO CALLED INDELS, IN REGIONS OF THE GENOME THAT DO NOT CODE FOR PROTEIN. THIS GENETIC MUTATION, WHICH OCCURS FREQUENTLY IN CANCER CELLS, MAY PROVIDE CLUES ABOUT THE DISEASES ORIGINS AND SERVE AS A BIOMARKER TO IMPROVE DIAGNOSIS AND TREATMENT. LATER IN THE YEAR, HE RECEIVED A CLINICAL SCIENTIST DEVELOPMENT AWARD FROM THE DORIS DUKE CHARITABLE FOUNDATION TO FUND HIS INVESTIGATION INTO UNDERSTANDING CANCER DRIVERS IN NON-CODING DNA THE 98 PERCENT OF THE GENOME THAT IS NOT TYPICALLY PROFILED IN STANDARD CLINICAL SEQUENCING TESTS. THE RESEARCH COULD REVEAL A NEW CLASS OF GENETIC MUTATIONS THAT DRIVE CANCER AND RESPONSE TO THERAPY. NYGC CORE FACULTY MEMBER NEVILLE SANJANA, PHD RECEIVED A SIDNEY KIMMEL FOUNDATION SCHOLAR AWARD AND A YOUNG INVESTIGATOR AWARD FROM THE MELANOMA RESEARCH ALLIANCE. THESE PRESTIGIOUS AWARDS FUND THE SANJANA LABORATORYS WORK IN LEVERAGING THE GENE-EDITING TOOL CRISPR TO COMPREHENSIVELY SURVEY MUTATIONS THAT ALLOW CANCER CELLS TO RESIST IMMUNOTHERAPY TREATMENT. NYGC CORE FACULTY MEMBER TUULI LAPPALAINEN, PHD RECEIVED A RESEARCH GRANT FROM THE NATIONAL INSTITUTES OF HEALTH TO FUND A STUDY TO BETTER UNDERSTAND VARIABLE PENETRANCE, A PHENOMENON WHERE THE SEVERITY OF THE EFFECT OF DISEASE-CAUSING GENETIC VARIANTS DIFFERS AMONG INDIVIDUALS WHO CARRY THEM. IN OCTOBER 2017, THE CHAN ZUCKERBERG INITIATIVE (CZI) AWARDED NYGC SCIENTISTS (TECHNOLOGY INNOVATION LABORATORY MANAGER PETER SMIBERT, PHD AND CORE FACULTY MEMBER RAHUL SATIJA, PHD, CO-PRINCIPAL INVESTIGATORS) A ONE-YEAR PILOT GRANT TO DEVELOP AN OPEN-SOURCE TOOLKIT FOR CITE-SEQ, THE SINGLE-CELL GENOMICS TOOL THAT WAS DEVELOPED BY NYGCS TECHNOLOGY INNOVATION LABORATORY EARLIER IN 2017. CITE-SEQ SIMULTANEOUSLY MEASURES PROTEIN AND RNA LEVELS IN THE LARGEST SCALE DEMONSTRATION OF MULTIDIMENSIONAL SINGLE-CELL ANALYSIS TO DATE. THE AWARD, FROM THE CZI DONOR-ADVISED FUND, AN ADVISED FUND OF THE SILICON VALLEY COMMUNITY FOUNDATION, WILL ENABLE RESEARCHERS TO LEVERAGE THIS POWERFUL TOOL FOR THE HUMAN CELL ATLAS PROJECT, THE INTERNATIONAL COLLABORATIVE EFFORT TO CREATE A COMPREHENSIVE REFERENCE MAP OF ALL HUMAN CELLS. PRIOR TO THE RECEIPT OF THE CZI GRANT, IN JULY 2017, NYGC SCIENTISTS PUBLISHED THEIR STUDY AND A DESCRIPTION OF CITE-SEQ IN NATURE METHODS. CITE-SEQ REPRESENTS AN IMPORTANT STEP FORWARD FOR SINGLE-CELL RNA SEQUENCING, AN ADVANCING FIELD OF GENOMICS THAT PROVIDES DETAILED INSIGHTS INTO INDIVIDUAL CELLS AND ENABLES RESEARCHERS TO DISTINGUISH BETWEEN DIFFERENT CELL TYPES AND TO STUDY DISEASE MECHANISMS AT THE LEVEL OF INDIVIDUAL CELLS. IN SEPTEMBER 2017, CELL PUBLISHED THE RESULTS OF A LARGE-SCALE WHOLE GENOME SEQUENCING STUDY AT NYGC THAT COMPARED THE WHOLE GENOMES OF 516 AUTISTIC CHILDREN WITH NO FAMILY HISTORY OF AUTISM WITH THE WHOLE GENOMES OF THEIR PARENTS AND AN UNAFFECTED SIBLING (2,064 PEOPLE IN TOTAL). RISK-RAISING MUTATIONS, WHICH OCCURRED IN CHILDREN BUT NOT THEIR PARENTS, WERE FOUND IN BOTH PROTEIN-CODING AND REGULATORY OR NON-CODING PORTIONS OF THE GENOME. THE STUDYS FINDINGS COULD HELP RESEARCHERS BETTER UNDERSTAND THE GENETIC SIGNATURES OF AUTISM, I.E., THE SUITE OF GENETIC ABNORMALITIES UNDERLYING THE DISORDER. THE RESEARCH WAS FUNDED BY A GRANT FROM THE NATIONAL HUMAN GENOME RESEARCH INSTITUTE, A DIVISION OF NIH, THAT ESTABLISHED NYGC AS A CENTER FOR COMMON DISEASE GENOMICS IN 2016. BIOINFORMATICS AND DATA MANAGEMENT NYGCS BIOINFORMATICS SCIENTISTS PLAY A LEADERSHIP ROLE IN THE COMPLEX ANALYSIS OF MULTIPLE DATASETS, INCLUDING INTEGRATING AND HARMONIZING CLINICAL AND GENOMIC DATA. NYGCS TEAM OF BIOINFORMATICIANS HAS EXPERTISE IN CANCER GENOMICS, STATISTICAL AND POPULATION GENETICS, EXPRESSION ANALYSIS, EPIGENOMICS AND FUNCTIONAL GENOMICS, TO NAME JUST A FEW. THEY DEVELOP, MAINTAIN AND IMPROVE DATA ANALYSIS PIPELINES BY LEVERAGING THE LARGE AMOUNTS OF SEQUENCING DATA PRODUCED AT THE CENTER. THEY WORK ON ESTIMATING THE SOURCES OF ERRORS AND VARIABILITY IN THE DATA, DEFINING METHODS TO CORRECT THEM, BOTH COMPUTATIONALLY AND ON THE LABORATORY SIDE. THEY ARE CONTINUALLY EVALUATING AND BENCHMARKING AVAILABLE TOOLS, REFINING BEST PRACTICES TO ANALYZE AND COMBINE RESULTS, AND ARE DEVELOPING NOVEL TOOLS AND METHODS FOR USE BY SCIENTISTS AROUND THE WORLD. IN 2017, OUR BIOINFORMATICS TEAM CONDUCTED AN ARRAY OF INVESTIGATIONS, INCLUDING RESEARCH ON HUMAN BRAIN DEVELOPMENT, RENAL CELL CARCINOMA, AUTISM AND BREAST CANCER. TECHNOLOGY INNOVATION TODAY, THERE ARE NUMEROUS EXCITING CLINICAL USES FOR GENOMIC INFORMATION, YET SUCH INFORMATION HAS TO BE GENERATED AND INTERPRETED IN A TIMELY, SCALABLE, AND HIGH-QUALITY FASHION IN ORDER TO SPEED AND IMPROVE THE DELIVERY OF RESULTS TO RESEARCHERS AND CLINICIANS. THE NYGC TECHNOLOGY INNOVATION LABORATORY IS A CREATIVE, MULTIDISCIPLINARY HUB WHERE SCIENTISTS ARE DEVELOPING CUTTING-EDGE TECHNOLOGIES TO ADVANCE GENOMICS RESEARCH AND CLINICAL APPLICATIONS, PARTICULARLY FOR CANCER RESEARCHERS AND CLINICIANS. THE TECHNOLOGY INNOVATION LABORATORY IS DEDICATED TO GENERATING NEW TECHNOLOGIES, PROTOCOL DEVELOPMENT, EQUIPMENT EVALUATION, AND INFORMATICS TOOL DEVELOPMENT/INTEGRATION. NYGC SCIENTISTS ARE DEVELOPING VARIOUS NOVEL TECHNOLOGIES TO SPEED UP, REDUCE COSTS OF AND DECREASE THE HANDLING OF NEXT-GENERATION LIBRARY PREPARATION REACTIONS.
EDUCATIONIN SUMMER 2017, NYGC COLLABORATED WITH THE NATIONAL CENTER FOR BIOTECHNOLOGY INFORMATION TO HOST A "GENOMICS HACKATHON." RESEARCHERS FROM NEW YORK CITY-AREA INSTITUTIONS AND BEYOND GATHERED AT NYGC TO TAKE PART IN A "SPRINT-LIKE" COLLABORATIVE WORKSHOP WHEREBY PARTICIPANTS INTENSIVELY WORKED TOGETHER ON COMPUTATIONAL PROJECTS RELATED TO GENOMICS AND CLINICAL RESEARCH. OVER A DOZEN TEAMS ASSEMBLED TO BRAINSTORM CREATION OF BIOINFORMATIC SOFTWARE, TOOLS FOR THE STUDY OF PROTEINS AND CANCER GENOMICS, AND PIPELINES TO ANALYZE LARGE-SCALE GENOMIC DATASETS. IN FALL 2017, NYGC LAUNCHED "GENOMIC INNOVATION," A 14-WEEK PROJECT-FOCUSED COURSE DEVELOPED BY NYGC CORE FACULTY MEMBERS NEVILLE SANJANA, PHD AND TUULI LAPPALAINEN, PHD. THE FOUR-CREDIT CLASS, THE FIRST-EVER GRADUATE-LEVEL COURSE TO BE HOSTED BY NYGC, INTRODUCED STUDENTS TO CUTTING-EDGE TECHNOLOGIES AND APPLICATIONS IN GENETICS AND GENOMICS AND THEIR RESPONSIBLE USE IN SCIENCE AND SOCIETY. GRADUATE STUDENTS FROM COLD SPRING HARBOR LABORATORY, COLUMBIA UNIVERSITY, ALBERT EINSTEIN COLLEGE OF MEDICINE, MOUNT SINAI SCHOOL OF MEDICINE (MSSM), MEMORIAL SLOAN-KETTERING CANCER CENTER (MSKCC), NEW YORK UNIVERSITY (NYU), THE ROCKEFELLER UNIVERSITY, STONY BROOK UNIVERSITY AND WEILL CORNELL MEDICINE (WCM) COULD RECEIVE CREDIT FOR THE CLASS THROUGH THEIR REGISTRARS OFFICE AND THE COURSE WAS OFFICIALLY LISTED IN THE COURSE CATALOGS OF COLUMBIA, NYU, AND EINSTEIN. THE FIRST CLASS INCLUDED STUDENTS FROM COLUMBIA, EINSTEIN, MSKCC, NYU, MSSM AND WCM. AS PART OF NYGCS EDUCATIONAL MISSION, THE CENTER HOSTED MANY SCIENTIFIC MEETINGS, WORKSHOPS, CONFERENCES AND LECTURES IN 2017. NYGC HELD "EVENING TALKS," A LECTURE SERIES FOR THE GENERAL PUBLIC ON ADVANCES IN GENOMIC SCIENCE, SPONSORED BY THE NEW YORK CITY COMMUNITY TRUSTPYEWACKET FUND. THE CENTER HOSTED "FIVE POINTS" LECTURES FOR THE SCIENTIFIC COMMUNITY, FEATURING LEADING RESEARCHERS FROM AROUND THE COUNTRY AND ABROAD. IN ADDITION, NYGC HELD WELL-ATTENDED WORKSHOPS FOR THE MEDICAL COMMUNITY ON SINGLE CELL GENOMICS, EPIGENOMICS, SEQUENCING INFORMATICS AND ANCESTRY. JLABS PARTNERSHIP IN JANUARY 2017, NYGC, JOHNSON & JOHNSON INNOVATION LLC AND NEW YORK STATE ANNOUNCED A COLLABORATION TO LAUNCH A NEW "JLABS" INCUBATOR IN NEW YORK CITY. CALLED "JLABS@NYCSCHEDULED TO OPEN IN SUMMER 2018, THE 30,000-SQUARE FOOT FACILITY ON THE THIRD FLOOR OF NYGC WILL HOUSE AS MANY AS 30 BIOTECH, PHARMACEUTICAL, MEDICAL DEVICE OR CONSUMER AND DIGITAL HEALTH COMPANIES. THE NEW ALLIANCE WAS FORGED TO SUPPORT THE GROWTH OF HEALTH CARE SOLUTIONS IN THE REGION BY PROVIDING A COMPREHENSIVE COMMERCIALIZATION VEHICLE FOR EMERGING LIFE SCIENCE COMPANIES. JLABS SUPPORT OF TALENTED SCIENTISTS IN THE CITY AS THEY TAKE THEIR INNOVATIVE IDEAS TO MARKET ALIGNS WITH NYGCS MISSION OF FOSTERING INTELLECTUALLY VIBRANT COLLABORATIONS THAT ADVANCE THE DEVELOPMENT OF NEW TREATMENTS, THERAPIES AND THERAPEUTICS AGAINST HUMAN DISEASE.
ORGANIZATION MEMBERSFORM 990, PART VI, SECTION A, LINE 6: AS OF DECEMBER 31, 2017, THE CENTER HAD A TOTAL OF 18 MEMBERS, CONSISTING OF 12 INSTITUTIONAL FOUNDING MEMBERS, FIVE ASSOCIATE MEMBERS, AND ONE FOUNDING TECHNOLOGY MEMBER. *THE INSTITUTIONAL FOUNDING MEMBERS ARE THE FOLLOWING RECOGNIZED ACADEMIC, MEDICAL AND RESEARCH INSTITUTIONS: (1) COLD SPRING HARBOR LABORATORY, (2) CORNELL UNIVERSITY/WEILL CORNELL MEDICINE, (3) THE JACKSON LABORATORY, (4) MEMORIAL SLOAN-KETTERING CANCER CENTER, (5) ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, (6) NEW YORK-PRESBYTERIAN HOSPITAL, (7) NEW YORK UNIVERSITY, SCHOOL OF MEDICINE, (8) NORTHWELL HEALTH, (9) THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK, ON BEHALF OF STONY BROOK UNIVERSITY, (10) THE ROCKEFELLER UNIVERSITY, (11) THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, AND (12) ALBERT EINSTEIN COLLEGE OF MEDICINE. *ASSOCIATE MEMBERS: (1) AMERICAN MUSEUM OF NATURAL HISTORY, (2) HOSPITAL FOR SPECIAL SURGERY, (3) THE NEW YORK STEM CELL FOUNDATION, AND (4) ROSWELL PARK CANCER INSTITUTE. (5) PRINCETON UNIVERSITY *FOUNDING TECHNOLOGY MEMBER: (1) INTERNATIONAL BUSINESS MACHINES (IBM)
ORGANIZATION MEMBERS - DECISION MAKINGFORM 990, PART VI, SECTION A, LINE 7A & 7B: EACH INSTITUTIONAL FOUNDING MEMBER APPOINTS ONE REPRESENTATIVE TO SERVE ON NYGCS BOARD OF DIRECTORS. THE BOARD OF DIRECTORS ALSO INCLUDES THE SCIENTIFIC DIRECTOR AND OTHER DESIGNATED DIRECTORS OR INDIVIDUALS APPOINTED BY THE BOARD. DECISIONS REQUIRING BOARD APPROVAL INCLUDE THE ADMISSION OF NEW MEMBERS, CHANGES TO THE MISSION, CERTIFICATE OF INCORPORATION, AND BYLAWS, APPOINTMENT OR REMOVAL OF THE CHAIRPERSON OF THE BOARD AND THE SCIENTIFIC DIRECTOR, AND ADOPTION OF CERTAIN POLICIES AND PROCEDURES. THE BOARD ALSO REVIEWS AND APPROVES THE ANNUAL OPERATING BUDGET. MANAGEMENT HAS THE ABILITY TO ENTER INTO BUSINESS ARRANGEMENTS AND CONTRACTS, INCLUDING FINANCING ARRANGEMENTS.
FORM 990 REVIEWFORM 990, PART VI, SECTION B, LINE 11: THE FORM 990 IS PREPARED BY AN INDEPENDENT PUBLIC ACCOUNTING FIRM, UTILIZING INFORMATION PROVIDED BY MANAGEMENT. UPON RECEIPT OF THE DRAFT FORM 990, MANAGEMENT, INCLUDING THE DIRECTOR OF FINANCE, GENERAL COUNSEL, AND PRESIDENT, REVIEW THE FORM. PRIOR TO FILING, MANAGEMENT PRESENTS THE FORM 990 TO THE AUDIT COMMITTEE FOR REVIEW AND COMMENT. ALSO PRIOR TO FILING, MANAGEMENT WILL MAKE THE FORM 990 AVAILABLE TO THE BOARD OF DIRECTORS.
CONFLICT OF INTEREST POLICY & REVIEWFORM 990, PART VI, SECTION B, LINE 12C: NYGC REQUIRES ALL INTERESTED PERSONS (DEFINED AS BOARD MEMBERS, PRINCIPAL OFFICERS, OR MEMBERS OF A COMMITTEE IN WHICH THE BOARD HAS DELEGATED POWERS) TO DISCLOSE CONFLICTS OF INTEREST AS REQUIRED BY THE CONFLICT OF INTEREST POLICY. NYGC FOLLOWS A PROCEDURE FOR OBTAINING SUCH DISCLOSURES ANNUALLY. ANY POTENTIAL CONFLICTS OF INTEREST MUST BE REVIEWED BY THE BOARD. IF AN INTERESTED PERSON HAS A POTENTIAL CONFLICT OF INTEREST, HE OR SHE MAY MAKE A PRESENTATION AT THE BOARD OR COMMITTEE MEETING, BUT AFTER SUCH PRESENTATION, HE/SHE SHALL LEAVE THE MEETING DURING THE DISCUSSION OF, AND THE VOTE ON, THE TRANSACTION OR ARRANGEMENT THAT CREATES THE POTENTIAL CONFLICT OF INTEREST.
COMPENSATION REVIEW AND APPROVALFORM 990, PART VI, SECTION B, LINE 15: FOR THE ORGANIZATIONS TOP MANAGEMENT OFFICIAL, PLEASE REFER TO SCHEDULE J NARRATIVES FOR PROCESS OF DETERMINING COMPENSATION. FOR ROBERT DARNELL, THE EXECUTIVE LEADERSHIP OF THE BOARD REVIEWED AND APPROVED HIS 2017 CONSULTING FEE. NYGC HIRED AN INDEPENDENT COMPENSATION CONSULTANT IN LATE 2016 TO REVIEW SENIOR MANAGEMENTS COMPENSATION. RESULTS OF THIS REVIEW WERE PROVIDED TO THE AD-HOC COMPENSATION COMMITTEE IN EARLY 2017. THE REVIEW SHOWED THAT THE COMPENSATION PAID TO ALL MEMBERS OF SENIOR MANAGEMENT WAS REASONABLE, AND THAT MERIT INCREASES FOR 2017 WERE REASONABLE AND APPROPRIATE. SENIOR MANAGEMENT EMPLOYED FOR MORE THAN 18 MONTHS RECEIVED A 4.5% MERIT INCREASE. SENIOR MANAGEMENT EMPLOYED FOR GREATER THAN ONE YEAR BUT LESS THAN 18 MONTHS RECEIVED A 3% MERIT INCREASE. THE PRESIDENT & COO DECLINED A MERIT INCREASE AND HER COMPENSATION WAS UNCHANGED. FORM 990, PART VII, LINE 40(B): DR. ROBERT DARNELL PROVIDED REGULAR CONSULTING SERVICES TO NYGC UNDER A CONSULTANT CONTRACT EXECUTED IN JANUARY 2017. THOSE CONSULTANCY HOURS ARE NOT REFLECTED IN LINE 40(B).
DOCUMENT DISCLOSUREFORM 990, PART VI, SECTION C, LINE 19: NYGC'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST.